Previous work has shown that retinoic acid receptors (RARs) and retinoid X receptors (RXRs) are expressed in human endometrial epithelial and stromal cells. These nuclear receptors mediate the biological effects of retinoic acid, a vitamin A derivative which may have an important, though poorly characterized role in the functional differentiation of secretory eprthelia. The aim of this study was to find out whether the expression of RAR and RXR mRNA in endometrial epithelial and stromal cells varies in relation to the menstrual cycle. The expression of RARs and RXRs was investigated by Northern blotting and, for stromal cells, there were no differences in expression of RAR-cc RAR-p\ RAR-y and RXR-a between the proliferative and secretory phases of the menstrual cycle. Similarly, for epithelial tissue, there were no significant differences between the proliferative and secretory phases with respect to the expression of RAR-oc RAR-y and RXR-a. However, RAR-p" was expressed at a 1.7-fold higher level in epithelial samples from the proliferative phase compared to the secretory phase. Overall, the levels of expression of RAR-oc RAR-p* and RAR-y were 1.7-to 4-fold higher in stromal cells compared to epithelial cells whereas RXR-a was expressed at a similar level in both cell types. We have previously suggested that retinoic acid has a role in endometrial differentiation or function which may be reflected by cyclical changes in intracellular retinoic acid levels. These data indicate that RARs and RXRs are expressed at a similar level throughout the menstrual cycle, with the possible exception of RAR-p\ implying that any menstrual cycle-related function of RARs is controlled by ligand availability rather than by changes in expression of the receptors.
Introduction
Despite the relative accessibility of human endometrium, the cellular mechanisms controlling its differentiation are poorly understood. Apart from the involvement of steroid hormones in controlling the apparent transition of the endometrium from a proliferative to a secretory phase (Witt and Thorneycroft, 1990) , little is known of other cellular factors controlling secretory differentiation. In previous studies, we have shown that mRNA for the nuclear retinoic acid receptors (RARs), RAR-a, RAR-P and RAR-y, and retinoid X receptor-a (RXR-a) are expressed in human endometrial stromal and epithelial cells in vitro (Prentice et al, 1992; Kumarendran et al, 1994; Siddiqui et al, 1994) and this suggests that retinoic acid, thought to be the main biologically-active form of vitamin A or retinol, may play a key role in endometrial differentiation. In their vitamin A deficiency studies on laboratory rats, published 70 years ago, Wolbach and Howe (1925) described the development of squamous keratinizing foci in the endometrium. More recent experimental work on other epithelia indicates that retinoic acid promotes glandular differentiation and that interactions with underlying connective tissue or stroma facilitate the effects of vitamin A (Covant and Hardy, 1990) . While these studies suggest that retinoic acid is potentially involved in controlling epithelial differentiation, there has been little progress in establishing whether or not retinoic acid has an intracellular role in endometrial epithelial differentiation in vivo.
RARs are retinoic acid-dependent transcriptional regulators and apparently function predominantly as heterodimers with RXRs (Stunnenberg, 1993) . RXRs have a pivotal role in RARmediated responses, apparently as ligand-independent cofactors (Xiao et al, 1995) . Temporal and spatial changes in RAR expression have been linked to the morphogenesis of epidermal structures in response to dermal instructions (Viallet and Dhouailly, 1994) and this raises the question whether or not RAR expression is regulated in relation to the cyclical proliferation and secretory differentiation of human endometrium. To address this question, we have studied RAR and RXR expression patterns in total RNA extracted from stromal and epithelial cells from endometrium biopsied throughout the menstrual cycle. Northern blot of endometnal RNA probed successively for retinoic acid receptors (RAR)-ot. RAR-|3. RAR-y. retinoid X receptor (RXR)-a and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). (A) Northern blot with endometnal epithelial and stromal cell RNA samples from series 1, gl = epithelial glands; s = stromal cells. S = cultured stromal cell standard; S + RA = cultured stromal cells treated with a\\-lrcins retinoic acid (Kumarendran et al.. 1994 ) (B) Northern blot of endometnal epithelial RNA samples from series 2
Materials and methods

Collection and processing of tissue samples
Endometnal samples were obtained from women undergoing laparoscopic sterilization, reversal of sterilization or diagnostic laparoscopy for potential benign pathology Endometnal samples were obtained only when the pelvis appeared normal. Subjects undergoing investigation for infertility or potential endometnal abnormality were excluded. All patients had a regular menstrual cycle (26-30 days). and none had taken an hormonal preparation in the preceding 3 months or were users of intrautenne contaceptive devices (IUCD) Fully-informed consent was obtained in accordance with the requirements of the joint Newcastle Health Authonty/University of Newcastle upon Tyne Ethical Committee. Biopsies were taken intra-operatively with a Pipelle de Cornier (Cornier, 1984, Eurosurgical, Nottingham. UK) , yielding ~l ml of tissue which was subsequently separated into stromal and glandular components as described by Matthews el al. 124 (1992) . Bnefly. minced tissue was disaggregated by digestion with collagenase (type 1A; Sigma. Poole. UK) and filtered through 45 (im and 10 urn sieves. Epithelial glands were harvested from the 45 (im sieve and the stromal cell-enriched fraction which passed through both sieves was further punfied by centrifugation over 60% Percoll (Pharmacia, Milton Keynes. UK) to remove contaminating erythrocytes.
RNA extraction and Northern blotting
Total RNA was extracted by lysis in guamdinium thiocyanate and purified by centrifugation for 2 h at 356 000 g through 5.7 M caesium chlonde (Chirgwine/a/., 1979) using a Beckman TLA 120 fixed-angle rotor (Beckman. High Wycombe. UK). RNA (up to 15 u.g per track) was size-fractionated by electrophoresis through 1.2% agarose/formaldehyde gels and blotted onto nylon membranes. Membranes were successively hybndized with '"P-labelled cDNA probes coding for human RAR-cc. RAR-(3. RAR-y. RXR-a. RXR-y 
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and rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) at 42°C as described previously (Prentice et ai, 1992; Redfem and Todd, 1992; Kumarendran et ai, 1994) , exposed to pre-flashed X-ray film and the resulting autoradiographs scanned using an image analysis system (Ultra-Violet Products, Cambridge, UK). Samples were collected as two independent series. In the first series, samples were obtained from 42 women but not all samples yielded sufficient RNA for analysis (see results). Epithelial and stromal cell RNA samples were loaded onto gels for analysis; each gel contained tracks of epithelial RNA, stromal cell RNA, an internal standard track containing an aliquot from a batch of RNA extracted from multiply-passaged stromal cells and a track containing RNA from retinoic acid-treated stromal cells (Kumarendran et ai, 1994) as a positive control for RAR-p. In the second series, samples of stromal and epithelial cells were obtained from 54 women; epithelial preparations yielded sufficient RNA (15-20 ug) for a single track but the yield of RNA from stromal cells was lower. Consequently, stromal cell samples were pooled, so that each resulting sample contained sufficient RNA for a gel track and was pooled from not more than two patients on equivalent days of their menstrual cycles. Samples were divided among gels according to the day of the menstrual cycle such that three gels contained even-day samples (day 2, day 4 etc) of epithelial RNA (two gels) or stromal cell RNA (one gel), and three gels contained odd-day samples of epithelial RNA (two gels) or stromal cell RNA (one gel), each gel containing samples encompassing the whole of the menstrual cycle. Aliquots of RNA extracted from cultured stromal cells were included as an internal standard on each gel, but this internal standard was prepared independently of the standard used for the first series. In addition, samples of RNA from KLE endometrial adenocarcinoma and CaCo-2 colon carcinoma cells (ATCC: HTB-37) were included on each gel as positive controls. The RXR-a data are for series 2 only.
Data analysis
To correct for differences in RNA loading, the signal intensity of each track for a given probe was expressed as a ratio with the signal intensity produced using the GAPDH probe. These figures were then expressed as a proportion of the (GAPDH-corrected) signal intensity for the internal standard track, thus allowing comparison between Northern blots within each series. The internal standards used in each series were prepared from different batches of cultured endometrial stromal cells and since these standards were not compared directly, it was not possible to make a direct comparison between the two series of samples. However, log-transformed data for each series were approximately normally distributed with similar SD. Therefore log-transformed data for the first series were scaled so that the means were equal to the second series. Statistical comparisons of probe signal intensity between the proliferative (days 2-14) and secretory (days 15-28) phases of the menstrual cycle were made using Wilcoxon's rank sum test on the combined data after back-transformation. Wilcoxon's rank sum test was used because it is more robust than the parametric alternative.
Results
Expression of RARs and RXRs in endometrial epithelial cells during the menstrual cycle
We have shown previously that human endometrial glandular epithelial cells cultured in vitro for 24 h express two RAR-a transcripts (-2.8 and 3.6 kb), two RAR-P transcripts (-3.1 and 3.4 kb) and RAR-y transcript(s) of ~3.1 kb (Siddiqui et ai, 1994) . With the exception of RAR-p where only the larger transcript was detectable, the pattern of RAR expression was qualitatively similar in freshly isolated endometrial epithelial tissue and did not vary during the menstrual cycle (Figures 1  and 2 ). Trie signal intensities produced using each RAR probe for samples throughout the menstrual cycle, relative to GAPDH and the stromal cell RNA internal standard, are summarized in Figure 2 . With respect to the proliferative (days 2-14) and secretory (days 15-28) phases of the menstrual cycle, there was no difference in expression of RAR-a or RAR-y [Wilcoxon Rank Sum test, data for series 1 and 2 combined: RAR-a, 3 . Scatterplot of integrated signal intensities from Northern blots of epithelial cell RNA probed for retinoid X receptor (RXR)-a, after correction for RNA loading using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and expressed relative to the internal standard RNA. .\-axis shows day of menstrual cycle; y-axis (logarithmic scale) shows relative signal intensity for RXR-a (series 2 samples only) P = 0.15 (not significant) n = 29, 40; RAR-y, P = 0.06 (not significant) n = 29, 41]. Although the data for RAR-fj do not suggest that there were major menstrual cycle-related changes, the median relative signal intensity was 1.7-fold higher in the proliferative phase (Wilcoxon Rank Sum test, data for series 1 and 2 combined: P = 0.02, n = 30, 41). In common with cultured endometrial epithelial cells (Siddiqui et al, 1994) , a single RXR-a transcript (>5 kb) was expressed in freshly isolated glandular epithelium (Figure 3) , and there were no apparent changes in expression during the menstrual cycle [Wilcoxon Rank Sum test, proliferative versus secretory phase, P = 0.3 (not significant), n = 26. 28J.
Expression ofRARs and RXRs in endometrial stromal cells during the menstrual cycle
The expression of RARs and RXRs has previously been characterized in cultured endometrial stromal cells (Prentice et al, 1992; Kumarendran et al, 1994; Siddiqui et al, 1994) . Freshly isolated stromal cells expressed all three RAR types and the transcript patterns for RAR-a and RAR-y were similar to cultured stromal cells. RAR-p\ however, was expressed as a single transcript (~3.4 kb) in freshly isolated cells ( Figure  4 ) whereas two transcripts are expressed in cultured and passaged stromal cells (Prentice et al, 1992; Kumarendran etal, 1994; Siddiqui etal, 1994) . The relative signal intensities are summarized in Figure 5 . There were no differences in expression of RAR-a, RAR-(i and RAR-y in the proliferative and secretory phases of the menstrual cycle [Wilcoxon Rank Sum test, data for series 1 and series 2 combined: RAR-a, P = 0.56 (not significant), n = 29, 40; RAR-p\ P = 0.23 (not significant), n = 16. 21; RAR-y, P = 0.97 (not significant) n = 16, 20].
RXR-a was expressed as a single band (>5 kb) in stromal cells (Figure 4) , as is the case in cultured and passaged cells (Kumarendran et al, 1994; Siddiqui et al, 1994) , and there were no menstrual cycle-related changes in expression ( 0.001 menstrual cycle (day) Figure 6 . Scatterplot of integrated signal intensities from Northern blots of stromal cell RNA probed for retinoid X receptor (RXR)-a, after correction for RNA loading using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and expressed relative to the internal standard RNA. *-axis shows day of menstrual cycle; ;y-axis (logarithmic scale) shows relative signal intensity for RXR-a (series 2 samples only).
6) [Wilcoxon Rank Sum test, P = 1.0 (not significant), n = 13, 14).
The relative expression of RARs and RXRs In endometrial epithelial and stromal cells
Since the same batch of RNA from cultured stromal cells was used as an internal standard on blots of epithelial and stromal cell RNA, RAR and RXR expression in the two tissue types may be compared, assuming that the level of expression of GAPDH is similar in endometrial stromal and epithelial cells. RAR-a, RAR-P and RAR-y were expressed at 4-fold, 1.7-fold and 3.5-fold higher levels respectively, in endometrial stromal cells compared to glandular epithelial cells (Wilcoxon Rank Sum test, combined data for series 1 and series 2: P < 0.001, for RAR-a, n = 36, 69; RAR-P, n = 37, 71; RAR-y, n = 36, 70). Conversely, there was no significant difference in expression of RXR-a between stromal cells and glandular epithelium [Wilcoxon Rank Sum test, P = 0.98 (not significant) n = 27, 54].
Discussion
The main conclusions from this study are that, firstly, with the exception of RAR-P in endometrial epithelial cells, there are no major changes in RAR and RXR-a expression patterns in endometrial epithelial and stromal cells in relation to proliferation and differentiation during the menstrual cycle. Secondly, RARs are expressed at a higher level, relative to GAPDH, in stromal cells than epithelial cells. It important to recognize that, with respect to changes in RAR expression in the proliferative versus secretory phases of the menstrual cycle, analysis of total RNA is relatively crude. For example, there may be subtle but biologically important changes in the proliferative and differentiated compartments of each endometrial gland that would be masked by this approach. The resolution of these experiments is also limited by the fact that samples were allocated to the proliferative and secretory phases with respect to day of the menstrual cycle rather than on the basis of precise physiological or histological criteria. This may have resulted in incorrect assignment for some samples with a resulting loss of statistical power in comparisons between the two phases. Nevertheless, the sample sizes are large and the results for RARs and RXR-a are in marked contrast to previous data for the expression of cellular retinoic acid binding protein II (CRABP II) mRNA which is significantly reduced in endometrial epithelial and stromal cells in the secretory phase of the menstrual cycle (Loughney et al., 1995) . CRABP II is a low molecular weight cytosolic protein which binds retinoic acid with high affinity (for a review see Chytil and Ong. 1984) . Its cellular function is unknown, but, on the basis of findings for a related protein, CRABP I (Boylan and Gudas, 1991) , it is thought to sequester retinoic acid and promote its conversion to inactive metabolites (Napoli, 1993) . However, a role in mediating the transfer of retinoic acid to the nucleus, as was proposed by Takase et al. (1986) , cannot be ruled out. The intracellular synthesis of retinoic acid from retinol is mediated by cellular retinol binding protein I (CRBP I). The expression of this gene remains at an apparently constant level in endometrial epithelial and stromal cells during the menstrual cycle (Loughney et al., 1995) and the decreased expression of CRABP II suggests that intracellular levels of retinoic acid may increase during the secretory phase of the menstrual cycle as a result of reduced retinoic acid degradation. Since RARs are ligand-dependent transcriptional regulators, it may be expected that, for short-term responses at least, the primary mechanism for regulating the activity of these receptors would be at the level of availability of ligand, rather than regulating the expression of the receptors themselves. The relatively constant level of RAR-a, RAR-yand RXR-a expression during the menstrual cycle is in accord with a model where the function of these receptors is regulated mainly by ligand availability.
The expression patterns of RAR-B in endometrial epithelial and stromal cells raises two issues. Firstly, with respect to stromal cells, we were unable to demonstrate an increase in RAR-B expression during the secretory phase of the cycle. Since RAR-B expression by stromal cells in vitro is induced in response to retinoic acid (Prentice et al., 1992) , we might expect to see an increase in RAR-B expression in vivo if intracellular retinoic acid levels increase during the secretory phase as a result of decreasing CRABP II expression. It has not been established whether or not stromal cells in vivo respond to retinoic acid with the induction of RAR-B, although this is the case for dermal fibroblasts (Viallet et al., 1991) . Nevertheless, additional transcription factors, such as those postulated by Bartsch et al. (1992) for HeLa cell derivatives in which RAR-B is refractory to induction by retinoic acid, may have an opposing negative or homeostatic effect on RAR-B expression by stromal cells in vivo. Secondly, with respect to epithelial cells, the data indicate a small (1.7-fold) but statistically significant decrease in RAR-B mRNA level in the secretory phase of the menstrual cycle. Since RAR-B expression may be linked to the differentiation of stratifying, squamous epithelia (Bartsch et al, 1992; Houle et al., 1993) , this change in the glandular epithelial cells may represent a real decrease associated with a glandular (as opposed to squamous) pathway of differentiation in endometrial epithelium.
The observation that, relative to GAPDH, RAR, but not RXR-a, expression levels are higher in stromal cells than in epithelial cells, suggests that retinoic acid may have greater importance for the developmental regulation of stromal cells. This supports the idea that stromal influences are important for directing the phenotype of associated epithelia, and that the effects of retinoic acid in promoting the glandular differentiation of other epithelia are mediated by the stromal or mesenchymal cells. Whether or not retinoic acid does have a role in the differentiation of endometrial epithelium needs to be established. Elucidating the potential involvement of retinoic acid in controlling endometrial differentiation and function may lead to radically new approaches to the treatment of endometrial disorders.
